Interventional Neurology Devices Market Report, Size, Share, Analysis 2017 and Forecast to 2023
Oct 11, 2017
According to Stratistics MRC,the Global Interventional Neurology Devices Market is accounted for $1.89 billion in 2016 and expected to grow at a CAGR of 10.3% to reach $3.76 billion by 2023.
Gaithersburg, Maryland, United States - October 11, 2017 /MarketersMedia/ —
The market factors such as growth due to obesity and aged population, rising frequency for hemorrhagic and ischemic stroke, ongoing product development and commercialization, expansion of healthcare infrastructure across emerging markets are propelling the market growth. However, stringent regulations and lack of talented neurologists are restraining the market growth. Increasing research activities in the field of neurovascular therapies, demand for minimally invasive neurosurgical procedures and surgeon’s awareness related to benefits of stereotactic framework procedures in neurosurgeries are creating wider opportunities for the market growth.
Request for sample here:
http://www.strategymrc.com/report/interventional-neurology-devices-market
Cerebral arteriovenous malformations and Dural Arteriovenous Fistulas (DAVFs) require complex treatment. The endovascular treatment with embolization is a fundamental component of the multidisciplinary management, together with radiosurgery and surgery. Microsurgery (ie, craniotomy followed by resection) has been reported to have a low risk of complications for in SMG I and II brain AVMs. Ischaemic strokes are caused by a blockage cutting off the blood supply to the brain. The blockage can be caused by a blood clot forming in an artery leading to the brain or within one of the small vessels deep inside the brain. Trials namely the ESCAPE, SWIFT PRIME, and EXTEND-IA studies also proved the effectiveness of mechanical thrombectomy in large vessel occlusion.
At present, Food and Drug Administration (FDA) approved the Pipeline embolization device (PED; Medtronic) for use in anterior circulation aneurysms. Presently, PED and its second generation, the Pipeline Flex, are the only flow diverters available in the United States. Internationally, the Silk device (Balt Extrusion), p64 flow modulation device (phenox GmbH), Flow Re-direction Endoluminal Device (FRED; MicroVention Terumo), and Surpass device (Stryker) are available. New coils, both pushable and detachable, have also recently been developed. The use of detachable coils with different lengths and volumes is on the rise, and a new coil without a metallic frame has also arrived to the market. The use of liquid embolic materials is increasing in peripheral applications. New materials are in the pipeline. For example, Squid is a non adhesive liquid embolic agent for embolization of brain Arteriovenous Malformations (AVM). It is composed of EVOH (ethylene vinyl alcohol copolymer) with suspended micronized Tantalum powder for radiopacity and DMSO (dimethyl sulfoxide) solvent. Squid must be injected through a DMSO compatible microcatheter.
Access the complete report at:
http://www.strategymrc.com/report/interventional-neurology-devices-market
Recently clot retrieval devices were approved by the FDA as first-line treatment along with IV rt-PA. The Penumbra Aspiration System, EmboTrap(®)II, stent retrievers, have the FDA clearance as first-line treatment for acute ischemic stroke along with IV rt-PA. Neurothrombectomy devices offer many potential advantages over pharmacologic thrombolysis, including more rapid achievement of recanalization, enhanced efficacy in treating large-vessel occlusions, and a potentially lower risk for hemorrhagic events. Currently, two neurothrombectomy devices are cleared by the U.S. Food and Drug Administration (FDA) through its 510(k) process: the MERCI Retriever (Concentric Medical) and the Penumbra System.
North America is expected to dominate the market owing to adoption of neurovascular devices among neurosurgeons in neurovascular disease treatment, growing number of clinical trials and significant medical reimbursement available in the U.S. for neurosurgical procedures.
The key players in Global Interventional Neurology Devices market are Abbott, Medtronic, Stryker, TERUMO, Acandis, B. Braun Melsungen, Bayer, Boston Scientific, Biosensors International, Covidien PLC, Integra LifeSciences Holdings Corporation, St. Jude Medical, Inc, W.L. Gore & Associates, Inc. and Magstim Co Ltd.
Make an inquiry at:
http://www.strategymrc.com/report/interventional-neurology-devices-market
Applications Covered:
• Arteriovenous Malformation and Fistulas
• Cerebral Aneurysms
• Schemic Strokes
• Intracranial Atherosclerotic Disease
Products Covered:
• Carotid Artery Angioplasty and Stenting
• Aneurysm Coiling and Embolization Devices
• Micro Support Devices
• Neurothrombectomy
Techniques Covered:
• Angioplasty & Stenting
• Neurothrombectomy
• Pre-operative Tumor Embolization
• Vertebroplasty
• Stroke Therapy
End Users Covered:
• Ambulatory Care Centers
• Hospitals
• Neurology Clinics
Regions Covered:
North America
US
Canada
Mexico
Europe
Germany
UK
Italy
France
Spain
Rest of Europe
Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
South America
Argentina
Brazil
Chile
Rest of South America
Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Follow us on Twitter:
https://twitter.com/StratisticsMRC
Follow us on LinkedIn at:
https://www.linkedin.com/company/stratistics-market-research-consulting-pvt-ltd?trk=mini-profile
About Stratistics MRC
We offer wide spectrum of research and consulting services with in-depth knowledge of different industries. We are known for customized research services, consulting services and Full Time Equivalent (FTE) services in the research world. We explore the market trends and draw our insights with valid assessments and analytical views. We use advanced techniques and tools among the quantitative and qualitative methodologies to identify the market trends.
Our research reports and publications are routed to help our clients to design their business models and enhance their business growth in the competitive market scenario. We have a strong team with hand-picked consultants including project managers, implementers, industry experts, researchers, research evaluators and analysts with years of experience in delivering the complex projects.
Contact Info:
Name: James Lamb
Email: Send Email
Organization: Stratistics Market Research Consulting Pvt Ltd
For more information, please visit http://www.strategymrc.com/
Source: MarketersMedia
Release ID: 248912
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.